Alterity Therapeutics (ATHE) Current Leases (2020 - 2025)

Alterity Therapeutics has reported Current Leases for 6 years, with the latest figure at $42852.7 in Q2 2025.

• For the quarter ending Q2 2025, Current Leases fell 39.3% year-over-year to $42852.7; the trailing twelve-month figure through Jun 2025 stood at $42852.7 (down 39.3% YoY), and the FY2025 full-year result was $42852.7, down 39.3% from the prior year.
• Current Leases for Q2 2025 stood at $42852.7, up from $41011.6 in the prior quarter.
• The five-year high for Current Leases was $71632.9 in Q2 2023, with the low at $21365.9 in Q2 2021.
• Average Current Leases over 5 years is $48124.2, with a median of $42066.3 recorded in 2022.
• Year-over-year, Current Leases soared 93.2% in 2022 and tumbled 39.3% in 2025.
• Tracing ATHE's Current Leases over 5 years: stood at $21365.9 in 2021, then soared by 93.2% to $41280.0 in 2022, then jumped by 73.53% to $71632.9 in 2023, then sank by 42.75% to $41011.6 in 2024, then gained by 4.49% to $42852.7 in 2025.
• The last three Current Leases figures came in at $42852.7 (Q2 2025), $41011.6 (Q4 2024), and $70602.0 (Q2 2024), per Business Quant data.

Peer Comparison